Screener / SEC EDGAR /CIK 0001650164 /10-K filed Feb 18, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Technology · Data Processing

Toast, Inc. TOST

Compare with peers Embed
Planned sales, announced before they happen

5 trading plans running, 50 Form 144 notices for $28.9M

10-Q, 10-K and Form 144
Plans running now 5 Aman Narang, Brian Elworthy, Elena Gomez, Jonathan Vassil
Plans adopted 21 reported since May 10, 2023 Form 144 notices 50 $28.9M the sellers expected to sell

What TOST's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Nov 26, 2024 to Aug 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Aman Narang
Chief Executive Officer and a member of our board of directors
Adopted 10b5-1 plan Mar 13, 2026 10-Q May 8, 2026
What the company wrote
On March 13, 2026, Aman Narang, our Chief Executive Officer and a member of our board of directors, the Narang Family Trust, and Starlight 2026 Charitable Remainder Trust (where shares held by such trusts are held indirectly by Mr. Narang), collectively entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. This trading plan provides for the sale from time to time of a maximum of 1,000,000 shares of our Class A common stock (500,000 shares contributed by Mr. Narang; 200,000 shares contributed by the Narang Family Trust; and 300,000 shares contributed by the Starlight 2026 Charitable Remainder Trust) pursuant to the terms of the plan. This trading plan expires on December 31, 2026, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Brian Elworthy
General Counsel and Corporate Secretary
Adopted 10b5-1 plan Feb 27, 2026 10-Q May 8, 2026
What the company wrote
On February 27, 2026, Brian Elworthy, our General Counsel and Corporate Secretary, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. This trading plan provides for the sale from time to time of a maximum of 108,000 shares of our Class A common stock pursuant to the terms of the plan. This trading plan expires on November 30, 2026, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Elena Gomez
President and Chief Financial Officer
Adopted 10b5-1 plan Dec 12, 2025 10-K Feb 18, 2026
What the company wrote
On December 12, 2025, Elena Gomez, our President and Chief Financial Officer, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. This trading plan provides for the sale from time to time of a maximum of 100,000 shares of our Class A common stock pursuant to the terms of the plan. This trading plan expires on April 30, 2027, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Jonathan Vassil
Chief Revenue Officer
Adopted other arrangement Sep 11, 2025 10-Q Nov 5, 2025
What the company wrote
On September 11, 2025, Jonathan Vassil, our Chief Revenue Officer entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. This trading plan provides for the sale from time to time of a maximum of 675,000 shares of our Class A common stock pursuant to the terms of the plan. This trading plan expires on June 30, 2026, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Brian Elworthy
General Counsel and Corporate Secretary
Adopted 10b5-1 plan Aug 19, 2025 10-Q Nov 5, 2025
What the company wrote
On August 19, 2025, Brian Elworthy, our General Counsel and Corporate Secretary entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. This trading plan provides for the sale from time to time of a maximum of 61,500 shares of our Class A common stock pursuant to the terms of the plan. This trading plan expires on May 15, 2026, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Aman Narang
Chief Executive Officer and a member of our Board of Directors
Adopted other arrangement Aug 18, 2025 10-Q Nov 5, 2025
What the company wrote
As previously disclosed in the Form 4 filed with the SEC on August 19, 2025, on August 18, 2025, Aman Narang, our Chief Executive Officer and a member of our Board of Directors, entered into a prepaid variable share forward contract with an unaffiliated dealer, which may constitute a non-Rule 10b5-1 trading arrangement (the “PVF Contract”). The PVF Contract obligates Mr. Narang to deliver to such unaffiliated dealer up to an aggregate of 500,000 shares of our Class A common stock (or cash if cash settlement is elected). The PVF Contract is expected to be settled in August 2027.
Brian Elworthy
General Counsel and Corporate Secretary
Adopted 10b5-1 plan Feb 26, 2025 10-Q May 9, 2025
What the company wrote
On February 26, 2025, Brian Elworthy, our General Counsel and Corporate Secretary, and Brian R. Elworthy Irrevocable Trust of 2019, where shares held by such trusts are held indirectly by Mr. Elworthy, collectively entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. This trading plan provides for the sale from time to time of a maximum of 339,368 shares of our Class A common stock (300,000 shares contributed by Mr. Elworthy; and 39,368 shares contributed by the Brian R. Elworthy Irrevocable Trust of 2019) pursuant to the terms of the plan. This trading plan expires on December 2, 2025, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Elena Gomez
President, Chief Financial Officer
Adopted 10b5-1 plan Dec 6, 2024 10-K Feb 26, 2025
What the company wrote
On December 6, 2024, Elena Gomez, our President, Chief Financial Officer, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. Ms. Gomez’s Rule 10b5-1 trading plan provides for the sale from time to time of a maximum of 100,000 shares of our Class A common stock pursuant to the terms of the plan. Ms. Gomez’s Rule 10b5-1 trading plan expires on March 1, 2026, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Stephen Fredette
President, Co-Founder and board member
Adopted 10b5-1 plan Dec 4, 2024 10-K Feb 26, 2025
Jonathan Vassil
Chief Revenue Officer
Adopted 10b5-1 plan Nov 26, 2024 10-K Feb 26, 2025
What the company wrote
On November 26, 2024, Jonathan Vassil, our Chief Revenue Officer, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. Mr. Vassil’s Rule 10b5-1 trading plan provides for the sale from time to time of a maximum of 400,000 shares of our Class A common stock pursuant to the terms of the plan. Mr. Vassil’s Rule 10b5-1 trading plan expires on November 21, 2025, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Christopher P. Comparato
board member
Adopted 10b5-1 plan Nov 18, 2024 10-K Feb 26, 2025
What the company wrote
On November 18, 2024, Christopher P. Comparato, our board member, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. Mr. Comparato’s Rule 10b5-1 trading plan provides for the sale from time to time of a maximum of 635,000 shares of our Class A common stock and the donation from time to time of a maximum of 40,000 shares of our Class A common stock pursuant to the terms of the plan. Mr. Comparato’s Rule 10b5-1 trading plan expires on December 31, 2025, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Narang Family Trust
Chief Executive Officer, Co-Founder and board member
Adopted 10b5-1 plan Sep 13, 2024 10-Q Nov 8, 2024
What the company wrote
On September 13, 2024, the Narang Family Trust, where shares held by such trust are held indirectly by Aman Narang, our Chief Executive Officer, Co-Founder and board member, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. This Rule 10b5-1 trading plan provides for the sale from time to time of a maximum of 720,000 shares of our Class A common stock pursuant to the terms of the plan and expires on September 12, 2025, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Brian Elworthy
General Counsel and Corporate Secretary
Adopted 10b5-1 plan Aug 30, 2024 10-Q Nov 8, 2024
What the company wrote
On August 30, 2024, Brian Elworthy, our General Counsel and Corporate Secretary, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. Mr. Elworthy’s Rule 10b5-1 trading plan provides for the sale from time to time of a maximum of 300,000 shares of our Class A common stock pursuant to the terms of the plan. Mr. Elworthy’s Rule 10b5-1 trading plan expires on May 30, 2025, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Stephen Fredette
President, Co-Founder and board member
Adopted 10b5-1 plan Jun 11, 2024 10-Q Aug 7, 2024
What the company wrote
On June 11, 2024, Stephen Fredette, our President, Co-Founder and board member, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. Mr. Fredette’s Rule 10b5-1 trading plan provides for the sale from time to time of a maximum of 963,444 shares of our Class A common stock and the donation from time to time of a maximum of 500,000 shares of our Class A common stock pursuant to the terms of the plan. Mr. Fredette’s Rule 10b5-1 trading plan expires on March 6, 2025, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Jonathan Vassil
Chief Revenue Officer
Adopted 10b5-1 plan May 31, 2024 10-Q Aug 7, 2024
What the company wrote
On May 31, 2024, Jonathan Vassil, our Chief Revenue Officer, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. Mr. Vassil's Rule 10b5-1 trading plan provides for the sale from time to time of a maximum of 150,000 shares of our Class A common stock pursuant to the terms of the plan. Mr. Vassil's Rule 10b5-1 trading plan expires on February 28, 2025, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Christopher P. Comparato
board member
Adopted 10b5-1 plan Mar 1, 2024 10-Q May 8, 2024
What the company wrote
On March 1, 2024, Christopher P. Comparato, our board member, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. Mr. Comparato’s Rule 10b5-1 trading plan provides for the sale from time to time of a maximum of 790,000 shares of our Class A common stock pursuant to the terms of the plan. Mr. Comparato’s Rule 10b5-1 trading plan expires on December 31, 2024, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Brian Elworthy
General Counsel and Corporate Secretary
Adopted 10b5-1 plan Feb 26, 2024 10-Q May 8, 2024
What the company wrote
On February 26, 2024, Brian Elworthy, our General Counsel and Corporate Secretary, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. Mr. Elworthy’s Rule 10b5-1 trading plan provides for the sale from time to time of a maximum of 300,000 shares of our Class A common stock pursuant to the terms of the plan. Mr. Elworthy’s Rule 10b5-1 trading plan expires on November 29, 2024, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Elena Gomez
Chief Financial Officer
Adopted 10b5-1 plan Dec 14, 2023 10-K Feb 27, 2024
What the company wrote
On December 14, 2023, Elena Gomez, our Chief Financial Officer, entered into a trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, referred to as the Exchange Act. Ms. Gomez's Rule 10b5-1 trading plan provides for the sale from time to time of a maximum of 91,664 shares of our Class A common stock pursuant to the terms of the plan. Ms. Gomez's Rule 10b5-1 trading plan expires on March 31, 2025, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Jonathan Vassil
Chief Revenue Officer
Adopted 10b5-1 plan Dec 14, 2023 10-K Feb 27, 2024
What the company wrote
On December 14, 2023, Jonathan Vassil, our Chief Revenue Officer, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. Mr. Vassil's Rule 10b5-1 trading plan provides for the sale from time to time of a maximum of 300,000 shares of our Class A common stock pursuant to the terms of the plan. Mr. Vassil's Rule 10b5-1 trading plan expires on August 30, 2024, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Aman Narang
Chief Executive Officer
Ended 10b5-1 plan Dec 1, 2023 10-K Feb 27, 2024
What the company wrote
On December 1, 2023, Aman Narang, our co-founder and board member, serving then as our Chief Operating Officer and currently as our Chief Executive Officer, terminated a pre-arranged stock trading plan pursuant to Rule 10b5-1 under the Exchange Act, which was adopted on February 24, 2023 with an original expiration date of October 16, 2024. The trading arrangement was intended to satisfy the affirmative defense in Rule 10b5-1(c). Mr. Narang’s pre-arranged stock trading plan provided for the sale of up to 5,446,666 shares of our Class A common stock pursuant to the terms of the plan, an aggregate of 248,509 shares were sold during the time period from February 24, 2023 through December 1, 2023.
Brian Elworthy
General Counsel and Corporate Secretary
Adopted 10b5-1 plan Sep 8, 2023 10-Q Nov 8, 2023
What the company wrote
On September 8, 2023, Brian Elworthy, our General Counsel and Corporate Secretary, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. Mr. Elworthy’s Rule 10b5-1 trading plan provides for the sale from time to time of a maximum of 263,534 shares of our Class A common stock pursuant to the terms of the plan. Mr. Elworthy’s Rule 10b5-1 trading plan expires on May 31, 2024, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Jonathan Vassil
Chief Revenue Officer,
Adopted 10b5-1 plan – 10-Q May 8, 2026
What the company wrote
On March 13, 2026, Jonathan Vassil, our Chief Revenue Officer, entered into a trading plan pursuant to Rule 10b5-1 of the Exchange Act. This trading plan provides for the sale from time to time of a maximum of 612,766 shares of our Class A common stock pursuant to the terms of the plan. This trading plan expires on January 29, 2027, or earlier if all transactions under the trading arrangement are completed. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
Show the other 14 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 10, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 12, 2026 Chapman-Hughes Susan
Director
6,885 $235K
Nov 4, 2026 Vassil Jonathan
Officer
4,600 $166K
Nov 2, 2026 Vassil Jonathan
Officer
14,280 $481K
Oct 5, 2026 Vassil Jonathan
Officer
7,623 $230K
Oct 2, 2026 Vassil Jonathan
Officer
6,657 $200K
Oct 2, 2026 Vassil Jonathan
Officer
6,808 $200K
Oct 2, 2026 Gomez Elena
Officer
11,886 $349K
Oct 2, 2026 Narang Aman
Officer, Director
14,713 $432K
Oct 2, 2026 Fredette Stephen
Officer, Director
9,368 $275K
Oct 2, 2026 Elworthy Brian R
Officer
6,507 $191K
Sep 2, 2026 Vassil Jonathan
Officer
14,280 $468K
Aug 21, 2026 Vassil Jonathan
Officer
85,280 $3.1M
Aug 19, 2026 Vassil Jonathan
Officer
13,931 $502K
Aug 11, 2026 Vassil Jonathan
Officer
13,797 $497K
Aug 10, 2026 Narang Aman
Officer, Director
119,843 $4.2M
Aug 10, 2026 Gomez Elena
Officer
5,761 $204K
Aug 7, 2026 Narang Aman
Officer, Director
42,105 $1.5M
Aug 7, 2026 Gomez Elena
Officer
2,163 $76K
Aug 6, 2026 Gomez Elena
Officer
900 $32K
Aug 6, 2026 Narang Aman
Officer, Director
13,510 $473K
Aug 5, 2026 Narang Aman
Officer, Director
124,542 $4.4M
Aug 5, 2026 Gomez Elena
Officer
16,176 $571K
Aug 5, 2026 Vassil Jonathan
Officer
4,700 $169K
Aug 3, 2026 Vassil Jonathan
Officer
14,280 $467K
Jul 14, 2026 Vassil Jonathan
Officer
2,000 $60K
Jul 13, 2026 Vassil Jonathan
Officer
9,170 $277K
Jul 7, 2026 Vassil Jonathan
Officer
3,150 $95K
Jul 2, 2026 Fredette Stephen
Officer, Director
9,146 $264K
Jul 2, 2026 Elworthy Brian R
Officer
6,352 $183K
Jul 2, 2026 Gomez Elena
Officer
11,605 $335K
Jul 2, 2026 Narang Aman
Officer, Director
14,365 $414K
Jul 2, 2026 Vassil Jonathan
Officer
6,647 $192K
May 29, 2026 Elworthy Brian R
Officer
108,000 $2.8M
Apr 2, 2026 Gomez Elena
Officer
8,929 $244K
Apr 2, 2026 Narang Aman
Officer, Director
13,463 $353K
Apr 2, 2026 Fredette Stephen
Officer, Director
7,289 $191K
Apr 2, 2026 Elworthy Brian R
Officer
3,664 $96K
Apr 2, 2026 Vassil Jonathan
Officer
6,438 $169K
Mar 12, 2026 Chapman-Hughes Susan
Director
8,500 $246K
Feb 3, 2026 Vassil Jonathan
Officer
1,454 $44K
Feb 3, 2026 Elworthy Brian R
Officer
648 $20K
Feb 3, 2026 Fredette Stephen
Officer, Director
1,060 $32K
Feb 3, 2026 Narang Aman
Officer, Director
1,648 $50K
Feb 3, 2026 Gomez Elena
Officer
1,437 $44K
Jan 5, 2026 Vassil Jonathan
Officer
4,787 $165K
Jan 5, 2026 Narang Aman
Officer, Director
8,591 $295K
Jan 5, 2026 Gomez Elena
Officer
6,672 $229K
Jan 5, 2026 Fredette Stephen
Officer, Director
4,866 $167K
Jan 5, 2026 Elworthy Brian R
Officer
3,303 $114K
Jan 2, 2026 Vassil Jonathan
Officer
66,390 $2.4M
Show the other 42 notices

From the Form 144 XML filed with the SEC, since Jan 2, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/TOST/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.